Because APOE4 is the greatest genetic risk factor for AD and rapamycin can modulate the adverse physiologic consequences of APOE4, this agent could be considered as a prophylactic measure for APOE4 carriers. The gene discussed is APOE; the disease is Alzheimer disease.